Follow us for updates
© 2021 reportr.world
Read the Story →

Pfizer is Working on an Omicron Vaccine, in Case Needed

Existing jabs still provide protection, CEO says.
by Agence France Presse
A day ago
Photo/s: Shutterstock
Shares

Pfizer said Monday it started working on a version of its COVID-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain.

The U.S. drugmaker's CEO, Albert Bourla, told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and has reignited fears of a global wave of COVID-19 infections.

"I don't think the result will be the vaccines don't protect," Bourla said. 

But the testing could show that existing shots "protect less," which would mean "that we need to create a new vaccine," Bourla said. 

"Friday we made our first DNA template, which is the first possible inflection of the development process of a new vaccine," he said.

MORE ON OMICRON VARIANT:

Omicron in Philippines a 'Matter of When', Face Shields Add Protection: Duque

Metro Manila Stays Under Alert Level 2 as World Watches Omicron Variant

Continue reading below ↓

Philippines Shuts Borders to Foreign Tourists Due to Omicron

Johnson & Johnson also said Monday that it was "pursuing an Omicron-specific variant vaccine and will progress it as needed."

On Friday, Moderna, another leading COVID-19 vaccine maker, said it was developing a booster shot against the new variant.

Bourla likened the situation to the scenario earlier this year when Pfizer and its German partner BioNTech developed a vaccine in 95 days when there were concerns the previous formula would not work against Delta, though that version ultimately was not used. 

The current vaccine is "very effective" against Delta, the executive said, adding that the companies expect to be able to produce four billion vaccine doses in 2022.

Continue reading below ↓
Recommended Videos

On Monday, the World Health Organization warned the new COVID-19 Omicron variant poses a "very high" risk globally.

Bourla said he was also "very confident" that Pfizer's recently unveiled antiviral pill would work as a treatment for infections caused by the mutations, including Omicron. 

Continue reading below ↓

Among newly-infected, high risk patients treated within three days of the onset of symptoms, Pfizer's pill has been shown to cut hospitalization or death by nearly 90%.

OMICRON VARIANT, EXPLAINED:

What is the Omicron Variant That's Got the World Worried?

EXPLAINER: How Omicron, Other Coronavirus Variants are Found

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.